Cellyan Biotechnology (HKPD) Total Debt (2024 - 2025)
Cellyan Biotechnology (HKPD) reported Total Debt of $355466.0 for Q3 2025, down 64.91% year-over-year from $1.0 million in Q3 2024, and down 81.05% quarter-over-quarter from $1.9 million in Q1 2025.
Cellyan Biotechnology (HKPD) Total Debt (2024 - 2025) Analysis & Trends
Cellyan Biotechnology (HKPD) has 2 years of Total Debt data on file, last reported at $355466.0 in Q3 2025.
- Total Debt for Q3 2025 came in at $355466.0, down 64.91% year-over-year; the trailing twelve-month figure through Sep 2025 was $355466.0 (down 64.91% YoY), and the FY2025 annual result was $1.9 million, up 44.28% from the prior year.
- Total Debt declined to $355466.0 in Q3 2025 per HKPD's latest filing, from $1.9 million in the prior quarter.
- Over five years, Total Debt peaked at $1.9 million in Q1 2025 and troughed at $355466.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 2.00 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 6.56 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 12.39 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 8.92 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 2.36 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.10 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 19.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 26.45 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 9.20 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 355,466.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 355,466.00 |
| Mar 31, 2025 | 1.88 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.30 Mn |